CMAC 2010; 12(2) | CMAC

CMAC 2010; 12(2)

In vitro activity of 13 antimicrobials (amikacin, cefepime, cefoperazone, cefoperazone/sulbactam, cefotaxime, ceftazidime, …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):96-105
PDF

Objective. To study prospectively clinical course of hospital-acquired pneumonia (HAP), mortality, and risk factors for poor outcome as …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):106-116
PDF

Objective. To determine characteristics of community-acquired Legionella pneumonia depending on severity of the disease, identify …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):117-126
PDF

The emergence and spread of resistance to multiple classes of antimicrobials is a growing threat, especially in microorganisms causing …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):127-145
PDF

Beta-lactams remain one of the most commonly used antimicrobial classes in the treatment of community-acquired respiratory tract …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):146-153
PDF

Ciprofloxacin is the most known member of second generation quinolones, which is more active against gram-negative microorganisms and …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):154-162
PDF

In 2010 the world celebrates the 65th anniversary when the Nobel Prize in Physiology or Medicine was awarded to A. Fleming, H. Florey, …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):163-169
PDF

Galenophyllipt is a new natural antiseptic for oral administration and topical use that is similar to commercially available medicinal …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):170-176
PDF